These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16280698)

  • 21. Screening for substance abuse and psychiatric disorders among women patients in a VA Health Care System.
    Davis TM; Bush KR; Kivlahan DR; Dobie DJ; Bradley KA
    Psychiatr Serv; 2003 Feb; 54(2):214-8. PubMed ID: 12556603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the efficiency of drug use disorder screening in psychiatric settings: validation of a single-item screen.
    Hearon BA; Pierce CL; Björgvinsson T; Fitzmaurice GM; Greenfield SF; Weiss RD; Busch AB
    Am J Drug Alcohol Abuse; 2015 Mar; 41(2):173-6. PubMed ID: 25700005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
    Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R
    Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid and Accurate Behavioral Health Diagnostic Screening: Initial Validation Study of a Web-Based, Self-Report Tool (the SAGE-SR).
    Brodey B; Purcell SE; Rhea K; Maier P; First M; Zweede L; Sinisterra M; Nunn MB; Austin MP; Brodey IS
    J Med Internet Res; 2018 Mar; 20(3):e108. PubMed ID: 29572204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of a brief mental health screener for Karen refugees in primary care.
    Brink DR; Shannon PJ; Vinson GA
    Fam Pract; 2016 Feb; 33(1):107-11. PubMed ID: 26613619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substance abuse/mental illness: diagnostic issues.
    Ford J; Hillard JR; Giesler LJ; Lassen KL; Thomas H
    Am J Drug Alcohol Abuse; 1989; 15(3):297-307. PubMed ID: 2763985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for mental health problems among patients with substance use disorders: preliminary findings on the validation of a self-assessment instrument.
    Castel S; Rush B; Kennedy S; Fulton K; Toneatto T
    Can J Psychiatry; 2007 Jan; 52(1):22-7. PubMed ID: 17444075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An electronic screen for triaging adolescent substance use by risk levels.
    Levy S; Weiss R; Sherritt L; Ziemnik R; Spalding A; Van Hook S; Shrier LA
    JAMA Pediatr; 2014 Sep; 168(9):822-8. PubMed ID: 25070067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening and brief intervention for alcohol and other abuse.
    Harris SK; Louis-Jacques J; Knight JR
    Adolesc Med State Art Rev; 2014 Apr; 25(1):126-56. PubMed ID: 25022191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
    Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
    Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening in Primary Care: What Is the Best Way to Identify At-Risk Youth for Substance Use?
    D'Amico EJ; Parast L; Meredith LS; Ewing BA; Shadel WG; Stein BD
    Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brief screening for co-occurring disorders among women entering substance abuse treatment.
    Lincoln AK; Liebschutz JM; Chernoff M; Nguyen D; Amaro H
    Subst Abuse Treat Prev Policy; 2006 Sep; 1():26. PubMed ID: 16959041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V.
    Nunes EV; Rounsaville BJ
    Addiction; 2006 Sep; 101 Suppl 1():89-96. PubMed ID: 16930164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of patients attending an HIV-related psychiatric clinic.
    O'Dowd MA; Natali C; Orr D; McKegney FP
    Hosp Community Psychiatry; 1991 Jun; 42(6):615-9. PubMed ID: 1864572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Drug Abuse Screening Test preserves its excellent psychometric properties in psychiatric patients evaluated in an emergency setting.
    Giguère CÉ; Potvin S;
    Addict Behav; 2017 Jan; 64():165-170. PubMed ID: 27614056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual diagnosis: HIV and mental illness, a population-based study.
    Stoskopf CH; Kim YK; Glover SH
    Community Ment Health J; 2001 Dec; 37(6):469-79. PubMed ID: 11504140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability and Validity of a Two-Question Version of the World Health Organization's Alcohol, Smoking and Substance Involvement Screening Test: The ASSIST-FC.
    McRee B; Babor TF; Lynch ML; Vendetti JA
    J Stud Alcohol Drugs; 2018 Jul; 79(4):649-657. PubMed ID: 30079882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance abuse and HIV.
    Hsu JH
    Hopkins HIV Rep; 2002 Jul; 14(4):8-12. PubMed ID: 12116984
    [No Abstract]   [Full Text] [Related]  

  • 39. Reliability of the Mood Disorder Questionnaire: comparison with the Structured Clinical Interview for the DSM-IV-TR in a population sample.
    Dodd S; Williams LJ; Jacka FN; Pasco JA; Bjerkeset O; Berk M
    Aust N Z J Psychiatry; 2009 Jun; 43(6):526-30. PubMed ID: 19440884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
    Chander G; Himelhoch S; Moore RD
    Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.